KLRK1 and metastatic malignant neoplasm: The susceptibility of metastatic cancer cells to NK cell-mediated lysis was investigated by comparing the levels of activating NKG2D ligands and of TRAIL receptors (DR4 and DR5) between KM12C, KM12L4A and KM12SM cells (Fig. 3).